Investment continues in cell and gene sector, despite disruptions
Investment in the cell and gene therapy sector remains robust, despite the disruptions over the last several years due to the COVID-19 pandemic. That's one of the take-home messages from this week's Cell & Gene Meeting on the Mediterranean, according to ScienceBoard Vice President of Digital Media Sales Walt Schoenborn and reporter Melisande Rouger, who were on site in Barcelona, Spain. Read More
Regional government steps in to boost gene therapy manufacturing in Spain
BARCELONA, SPAIN -- Early cooperation between the government of the Basque region in northern Spain and companies can help boost manufacturing of gene therapies, according to Gotzone Sagardui, health minister for the Basque Country. ScienceBoard.net spoke with Sagardui during the Cell & Gene Meeting on the Med earlier this week. Read More
Context Therapeutics highlights data on ONA-XR and CLDN6 at AACR 2022
Context Therapeutics released preclinical data from two of its clinical programs to treat women’s cancers at the American Association for Cancer Research (AACR) annual meeting. ScienceBoard spoke with Context Therapeutics CEO and co-founder Martin Lehr at the show. Read More
Meeting on the Med opens with new data and eyes on the money
BARCELONA, SPAIN -- The Cell & Gene Meeting on the Med conference kicked off on April 20 as speakers assessed the current state of the cell and gene therapy sector and explored payment strategies for advanced therapies across the European Union. Read More
MASTER technology could transform CAR T-cell therapy
A new technology that helps CAR T cells attack cancer cells more aggressively than conventional methods has been published by researchers from North Carolina. Called multifunctional alginate scaffold for T-cell engineering and release (MASTER), the technology was described in a paper published on March 24 in Nature Biotechnology. Read More
Purigen enters into distribution agreement with GC biotech
Purigen Biosystems has entered into a distribution agreement with GC biotech in support of its automated Ionic Purification System. The agreement gives GC biotech rights in Europe to distribute, service, and support the purification system, in addition to microfluidics kits. Read More
Conferences
Science Briefs
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
